Journal of the American Academy of Dermatology
Volume 50, Issue 6 , Pages 907-912, June 2004

Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea☆☆

  • Jonathan Wilkin, MD, Chair

      Affiliations

    • Division of Dermatologic and Dental Drug Products, Food and Drug Administration, Rockville, Maryland, USA
  • ,
  • Mark Dahl, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA
  • ,
  • Michael Detmar, MD

      Affiliations

    • Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
  • ,
  • Lynn Drake, MD

      Affiliations

    • Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA
  • ,
  • Matthew H Liang, MD, MPH

      Affiliations

    • Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA
  • ,
  • Richard Odom, MD

      Affiliations

    • Department of Dermatology, University of California San Francisco, San Francisco, California, USA
  • ,
  • Frank Powell, MD

      Affiliations

    • Regional Centre of Dermatology, Mater Misericordiae Hospital, Dublin, Ireland
    • Corresponding Author InformationReprint requests: National Rosacea Society, 800 S Northwest Highway, Suite 200, Barrington, IL 60010, USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the National Rosacea Society.Conflicts of interest: None identified.The opinions set forth in this report are those of the committee members and do not represent the Food and Drug Administration in any way.

☆☆ The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to support rosacea research, including the awarding of research grants, and to provide educational information on rosacea to physicians, patients, and the public.

PII: S0190-9622(04)00535-3

doi:10.1016/j.jaad.2004.01.048

Journal of the American Academy of Dermatology
Volume 50, Issue 6 , Pages 907-912, June 2004